| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $64.90B | +1.2% |
| Cost of Revenue | $43.73B | +0.8% |
| R&D Expense | $1.15B | -11.4% |
| SG&A Expense | $4.28B | +0.1% |
| Operating Income | $9.60B | +8.9% |
| Interest Expense | $59.0M | +24.1% |
| Pre-tax Income | $9.70B | +6.1% |
| Income Tax | $2.28B | +6.8% |
| Net Income | $7.26B |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.00B | -44.7% |
| Short-term Investments | $5.4M | +17.9% |
| Accounts Receivable | $11.87B | +11.1% |
| Current Assets | $20.86B | -10.8% |
| Total Assets | $55.93B | +9.1% |
| Current Liabilities | $18.98B | +5.4% |
| Long-term Debt | $78.6M | +82.5% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $9.13B | -4.1% |
| Capital Expenditures | $516.5M | -2.2% |
| Investing Cash Flow | -$7.06B | -169.3% |
| Financing Cash Flow | -$6.06B | -7.4% |
| Free Cash Flow | $8.61B | -4.2% |
| +5.7% |
| EPS (Basic) | $11.57 | +6.1% |
| EPS (Diluted) | $11.44 | +6.2% |
| Stockholders' Equity |
| $28.29B |
| +10.1% |